{"retracted":false,"update":{"timestamp":1467936000000,"doi":"10.1371/journal.pone.0159286","type":"correction"},"doi":"10.1371/journal.pone.0155406","journal":"PLOS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy"}
